Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)
Miller Jm(Centers for Disease Control and Prevention), Joseph D. Yao(Mayo Clinic), Sam R. Telford(Tufts University), Robert C. Jerris(Children's Healthcare of Atlanta), James W. Snyder(University of Louisville), Barbara Robinson-Dunn(Beaumont Health), Karen C. Carroll(Johns Hopkins University), Sixto M. Leal(University of Alabama at Birmingham), Sandra S. Richter(Cleveland Clinic), Melvin P. Weinstein(Rutgers, The State University of New Jersey), Robin Patel(Mayo Clinic), Kimberle C. Chapin(Providence College), Sheldon Campbell(Yale University), Elitza S. Theel(Mayo Clinic), Sue C. Kehl(Medical College of Wisconsin), Richard B. Thomson(NorthShore University HealthSystem), Mark D. Gonzalez(Children's Healthcare of Atlanta), Matthew J. Binnicker(Mayo Clinic), Amanda Harrington(Loyola University Chicago), Bobbi S. Pritt(Mayo Clinic)
Cited by 259
Related Papers
Comparison of Levator Ani Muscle Defects and Function in Women With and Without Pelvic Organ Prolapse
|Obstetrics and Gynecology|2007|703
A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya
|Clinical Infectious Diseases|2018|618
A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2013 Recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)a
|Clinical Infectious Diseases|2013|591
Classification, Identification, and Clinical Significance of Proteus, Providencia, and Morganella
|Clinical Microbiology Reviews|2000|587
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
|New England Journal of Medicine|2021|553